Gainers
OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Avaya Holdings Corp. (NYSE:AVYA) ("Avaya" or "the Company") today publicly disclosed certain business information that it confidentially shared with certain of its financial stakeholders. This